Curis (CRIS) Invested Capital (2012 - 2025)

Curis' (CRIS) quarterly Invested Capital came in at $7.0 million in Q3 2025, down 5.47% on a QoQ basis from $7.4 million in Q2 2025.

Curis (CRIS) Invested Capital (2012 - 2025) Analysis & Trends

Curis (CRIS) has 12 years of Invested Capital data on file, last reported at $7.0 million in Q3 2025.

Quarterly Invested Capital changed N/A year-over-year to $7.0 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $14.3 million (down 3.29% YoY) and the FY2024 annual result came in at $7.6 million, down 11.15% from the prior year.
Invested Capital retreated to $7.0 million in Q3 2025, from $7.4 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $8.5 million in Q4 2023 to a low of $891000.0 in Q1 2021.
A 4-year average of $6.4 million and a median of $7.3 million in 2025 frame the typical range for Invested Capital.
The widest YoY moves for Invested Capital: up 11.15% in 2024, down 11.15% in 2024.
Tracing CRIS's Invested Capital over 4 years: stood at $891000.0 in 2021, then jumped by 854.43% to $8.5 million in 2023, then retreated by 11.15% to $7.6 million in 2024, then retreated by 8.01% to $7.0 million in 2025.
The last three Invested Capital figures came in at $7.0 million (Q3 2025), $7.4 million (Q2 2025), and $7.2 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	190.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.45 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	380.00 Mn
10	Curis	3.27 Mn	-2.35 Mn	-	-

Download Data